Ludo Haazen, M.D.

Ludo Haazen, M.D. has extensive work experience in the medical field. Ludo started their career in 1989 as a Medical Advisor at Roche. From 1995 to 2000, they were the Global Medical Leader and Global Project Leader at The Janssen Pharmaceutical Companies of Johnson & Johnson. In 2000, they became the Medical and Regulatory Affairs Director at Orthovita. Since 2003, they have been a Freelance Medical, Clinical and Pharmacovigilance Expert at Certor bvba, providing support to several Biotech companies. In 2014, they became a Lecturer and Examiner at the PHARMED post-graduate program in Pharmaceutical Medicine and Medicines Development Sciences and CliniX formation program at the Université libre de Bruxelles. In 2017, they became a Review Editor at Frontiers. In 2018, they became the Chief Medical Officer at Rejuvenate Biomed. In 2019, they became a Medical Consultant at Precigen ActoBio. In 2020, they became the Chief Medical Officer at MRM Health.

Ludo Haazen, M.D. received their MD from KU Leuven between 1978 and 1985, studying Medicine.